DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 8Alfred E Tiefenbacher GmbH
03 4Aucta Pharmaceuticals
04 1Strides Pharma Science
05 4ANGITA PHARMA INC.
06 20Accord healthcare
07 1Acella Pharmaceuticals
08 4Actavis Inc
09 4Alembic Pharmaceuticals Limited
10 5Alkem Laboratories
11 17Alphapharm PTY Ltd
12 5Amneal Pharmaceuticals
13 6Apotex Inc
14 4Aristo Pharma GmbH
15 17Arrotex Pharmaceuticals
16 1Aspiro Pharma
17 4Auro Pharma Inc
18 10Aurobindo Pharma Limited
19 1Chartwell Pharmaceuticals llc
20 9Cipla
21 5DOC Generici
22 11Desitin Arzneimittel
23 6EG Spa
24 6Ecupharma
25 1Fresenius Kabi USA
26 1GLAND PHARMA LIMITED
27 17Generic Health
28 5Glenmark Pharmaceuticals
29 1Hainan Poly Pharm
30 2Hameln Pharma GmbH
31 5Hetero Drugs
32 2Hikma Pharmaceuticals
33 9Indoco Remedies Limited
34 4Intas Pharmaceuticals
35 4JAMP PHARMA
36 4KANCHAN HLTHCARE
37 2Kolmar Korea Co., Ltd.
38 6Krka
39 4MINT PHARMACEUTICALS INC
40 6MSN Laboratories
41 4Macleods Pharmaceuticals Limited
42 4Medical Valley
43 1Medley Pharmaceuticals
44 10Mepha Pharma
45 5Neuraxpharm
46 4Nora Pharma
47 1Novitium Pharma LLC
48 4ORIFARM GROUP AS
49 4Orchid Pharma
50 21Pharmacore Inc
51 4Pharmascience Inc.
52 4SANIS HEALTH INC
53 5SF Group
54 39Sandoz B2B
55 4ScieGen Pharmaceuticals
56 4So.Se.Pharm
57 1Somerset Pharmaceuticals Inc
58 4Sun Pharmaceutical Industries Limited
59 5Tecnimede
60 14Teva Pharmaceutical Industries
61 4Torrent Pharmaceuticals Limited
62 86UCB Pharma S.A
63 4Unichem Laboratories Limited
64 4Unichem Pharmaceuticals USA, Inc
65 6Viatris
66 10Zentiva
67 5Zydus Pharmaceuticals
01 7Antic-calc Tablet, Film Coated
02 3CAPSULE, EXTENDED RELEASE;ORAL
03 4Effervescent Tablet
04 1Extended Release Capsule
05 5FILMDRAGERAD TABLETT
06 16Film Coated Tablet
07 2Film Coated Tablets
08 5Film-Coated Tablet
09 2Film-Coated Tablet Oral Use Blister
10 71Film-Coated Tablets
11 4Film-Coated Tablets Oral Use Blister
12 4Filmcoated Tablets Oral
13 8Filmtab
14 15Filmtabl
15 1INFUSIONSVÄTSKA, LÖSNING
16 1Infusion fluid, resolution
17 1Lacosamide 100Mg 14 Joined' Oral Use
18 1Lacosamide 100Mg 56 Combined Oral Use
19 1Lacosamide 150Mg 14 Joined' Oral Use
20 1Lacosamide 150Mg 56 Combined Oral Use
21 1Lacosamide 200Mg 56 Combined Oral Use
22 1Lacosamide 50Mg 14 Joined' Oral Use
23 1Lacosamide 50Mg 56 Combined Oral Use
24 10Lactab
25 2SIRAP
26 2SOLUTION
27 13SOLUTION;INTRAVENOUS
28 11SOLUTION;ORAL
29 1Sirup
30 4Solution for infusion
31 6Syrup
32 48TABLET
33 76TABLET;ORAL
34 14Tablet
35 20Tablet, film-coated
36 69tablet
37 56Blank
01 21DISCN
02 8Generic
03 4Generic EU CTD
04 77RX
05 8Registered in EU
06 370Blank
01 4ACH-LACOSAMIDE
02 4AG-LACOSAMIDE
03 4AURO-LACOSAMIDE
04 4JAMP-LACOSAMIDE
05 98LACOSAMIDE
06 6LACOSAMIDE ACCORD
07 4LACOSAMIDE ARISTO
08 5LACOSAMIDE AUROBINDO
09 5LACOSAMIDE DOC
10 6LACOSAMIDE EG
11 1LACOSAMIDE INJECTION, USP
12 6LACOSAMIDE KRKA
13 6LACOSAMIDE MYLAN
14 6LACOSAMIDE SANDAZ
15 6LACOSAMIDE TEVA
16 6LACOSAMIDE ZENTIVA
17 4LAPRYSTA
18 9Lacoress
19 17Lacosam
20 11Lacosamid Desitin
21 6Lacosamid Sandoz
22 8Lacosamid-Mepha
23 17Lacosamide ARX
24 6Lacosamide Accord
25 17Lacosamide Lupin
26 4Lacosamide Medical Valley
27 23Lacosamide Sandoz
28 2Lacosamide hameln
29 2Lacosamide-Mepha
30 4MINT-LACOSAMIDE
31 3MOTPOLY XR
32 1Motpoly XR
33 5NEPILEX
34 4NRA-LACOSAMIDE
35 4OLLAT
36 4PHARMA-LACOSAMIDE
37 4SANDOZ LACOSAMIDE
38 6STUTAN
39 4TEVA-LACOSAMIDE
40 17VIMPAT
41 21Vimcosa
42 2Vimcosa Tablet
43 66Vimpat
44 7Vpat
45 39Blank
01 125Australia
02 46Canada
03 4Czech Republic
04 8Germany
05 21India
06 88Italy
07 34Norway
08 5Portugal
09 2South Korea
10 1Spain
11 8Sweden
12 42Switzerland
13 1U.S.A
14 103USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LACOSAMIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 200MG/20ML (10MG/ML)
Packaging :
Approval Date : 2024-03-25
Application Number : 217718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : MOTPOLY XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Syrup
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : MOTPOLY XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MOTPOLY XR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : U.S.A
Brand Name : Motpoly XR
Dosage Form : Extended Release Capsule
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide hameln
Dosage Form : Solution for infusion
Dosage Strength : 10 mg/ml
Packaging : Vials 1 20ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide hameln
Dosage Form : Solution for infusion
Dosage Strength : 10 mg/ml
Packaging : Vials 5 20ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : LACOSAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-03-17
Application Number : 204787
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LACOSAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-03-17
Application Number : 204787
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 50 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 200 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 150 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Lacosamide Medical Valley
Dosage Form : Tablet, film-coated
Dosage Strength : 100 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vimpat
Dosage Form : Tablet, film-coated
Dosage Strength : 150 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vimpat
Dosage Form : Tablet, film-coated
Dosage Strength : 100 mg
Packaging : Blisterpakning 56item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2008-10-28
Application Number : 22253
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 200MG/20ML (10MG/ML)
Packaging :
Approval Date : 2008-10-28
Application Number : 22254
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIMPAT
Dosage Form : SOLUTION;ORAL
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2010-04-20
Application Number : 22255
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?